Aperta Biosciences
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1108 Lavaca St Ste 110-329, Austin, Texa...Phone Number
(512) 270-3960Website
www.apertabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Aperta Biosciences
Aperta Biosciences is an emerging biopharma company dedicated to developing novel therapeutics for Ocular Surface Disease (OSD), particularly focusing on conditions such as blepharitis, ocular rosacea, meibomian gland dysfunction, and dry eye disease. The company aims to address not only the symptoms but also the underlying causes of blepharitis, with its lead program APT-001 targeting ocular demodicosis. Founded by a team with extensive experience in ophthalmic indications, Aperta is committed to advancing innovative treatment options for the millions affected by these conditions. Their approach emphasizes a new mechanism of action to effectively eradicate the root causes of blepharitis.Explore more
Aperta Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aperta Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aperta Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Aperta Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aperta Biosciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Aperta Biosciences
Check if Aperta Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Aperta Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Aperta Biosciences has new funding data
Earning: See what the market has to say on Aperta Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Aperta Biosciences
Find 2 more new buyers
Compare Similar Companies to Aperta Biosciences
Compare insights from companies similar to Aperta Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2016
Company Profile Activity
Activity Insights
Aperta Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aperta Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aperta Biosciences.
Aperta Biosciences Tech Stack
A closer look at the technologies used by Aperta Biosciences
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aperta Biosciences
Sign Up For FreeTo access detailed company insights
Aperta Biosciences is an emerging biopharma company dedicated to developing novel therapeutics for Ocular Surface Disease (OSD), particularly focusing on conditions such as blepharitis, ocular rosacea, meibomian gland dysfunction, and dry eye disease. The company aims to address not only the symptoms but also the underlying causes of blepharitis, w... Read More
